Terns Pharmaceuticals Inc

+0.42 (+7.49%)
4:22:15 PM EDT: $5.60 -0.43 (-7.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Terns Pharmaceuticals Inc Stock, NASDAQ:TERN

1065 East Hillsdale Boulevard, Suite 100, Foster City, California 94404
United States of America
Phone: +1.650.525.5535
Number of Employees: 41


Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-?? agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.